Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Kenvue Inc.

Mr. Thibaut  Mongon

CEO & Director

Mr. Paul  Ruh

Chief Financial Officer

Ms. Meredith  Stevens

Chief Operations Officer

Mr. Carlton  Lawson

Group President of EMEA & Latin America

Ms. Ellie Bing Xie

Group President of Asia Pacific

Ms. Heather R. Howlett

Chief Accounting Officer

Mr. Bernardo  Tavares

Chief Data & Technology Officer

Dr. Caroline  Tillett Ph.D.

Chief Scientific Officer

Ms. Tina  Romani

Head of Investor Relations

Mr. Matthew  Orlando

General Counsel

KVUE's next earnings is on February 6, 2025 (After Market Close)

KVUE's latest dividend is 0.205 USD on August 14, 2024

Kenvue Inc. (KVUE) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Kenvue Inc. (KVUE) Earnings Report Date and History | NYSE

KVUE's next earnings is on February 6, 2025 (After Market Close)

When is the earnings report for KVUE?

KVUE Earnings History

KVUE's latest dividend is 0.205 USD on August 14, 2024

KVUE Stock Discussion Forum and Message Board

News for NYSE: KVUE